Annual report pursuant to Section 13 and 15(d)

Intangible Assets - License Agreements (Details)

v3.6.0.2
Intangible Assets - License Agreements (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Sales and Marketing Expense    
Intangible assets    
Royalty fees included in sales and marketing expense $ 812,000 $ 526,000
Licensing Agreements    
Intangible assets    
License agreements extended period 60 days  
Minimum royalty of agreements $ 12,500  
Milestone fee upon receiving a Phase II Small Business Innovation Research 15,000  
Milestone fee upon FDA approval 2,000  
Milestone fee upon first commercial use of certain licensed technology 25,000  
Milestone fee upon first use to manufacture products that utilize certain technology not currently incorporated into AxoGen products $ 10,000  
Licensing Agreements | Minimum    
Intangible assets    
Royalty fees range under the license agreements 1.00%  
Licensing Agreements | Maximum    
Intangible assets    
Royalty fees range under the license agreements 3.00%  
Royalty stack cap for royalties paid to more than one licensor for sales of the same product 3.75%